Translational Research Using Microsamples

Rapid On-site Diagnostic Tool

We are developing a low-cost, easy to use, Rapid On-Site Evaluation Handheld Diagnostic (ROSEHD) device which will enable the rapid detection of lung cancer within a span of 5 minutes with a high degree of specificity, sensitivity, and accuracy. This technology will enable better treatment of lung cancer and improve health care efficiency by preventing delays in patient-care with off-site evaluation.

Genomic Profiling of Lung Cancer

Some patients may benefit from molecular-targeted agents. We are currently analyzing the tumor characters using EBUS-TBNA samples to explore different biomarkers for diagnosis and treatment of lung cancer.